Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated SteatohepatitisKosuke Kaji, Hitoshi Yoshiji|Antioxidants|2024Cited by 15